Switch to:

Alexion Pharmaceuticals Beneish M-Score

: -2.11 (As of Today)
View and export this data going back to 1996. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.

Alexion Pharmaceuticals has a M-score of -2.11 signals that the company is a manipulator.

NAS:ALXN' s Beneish M-Score Range Over the Past 10 Years
Min: -4.58   Med: -2.27   Max: 38.46
Current: -2.11

-4.58
38.46

During the past 13 years, the highest Beneish M-Score of Alexion Pharmaceuticals was 38.46. The lowest was -4.58. And the median was -2.27.


Alexion Pharmaceuticals Beneish M-Score Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Alexion Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.89 -2.52 -2.54 -1.93 -2.05

Alexion Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.08 -2.18 -2.05 -2.07 -2.11

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Alexion Pharmaceuticals Beneish M-Score Distribution

* The bar in red indicates where Alexion Pharmaceuticals's Beneish M-Score falls into.



Alexion Pharmaceuticals Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Alexion Pharmaceuticals for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9923+0.528 * 1.0015+0.404 * 0.9551+0.892 * 1.2307+0.115 * 1.1205
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9132+4.679 * 0.0239-0.327 * 0.8639
=-2.11

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

This Year (Jun20) TTM:Last Year (Jun19) TTM:
Accounts Receivable was $1,372 Mil.
Revenue was 1444.6 + 1444.8 + 1384.3 + 1263.1 = $5,537 Mil.
Gross Profit was 1299.7 + 1333.1 + 1270 + 1167.9 = $5,071 Mil.
Total Current Assets was $5,368 Mil.
Total Assets was $16,703 Mil.
Property, Plant and Equipment(Net PPE) was $1,406 Mil.
Depreciation, Depletion and Amortization(DDA) was $362 Mil.
Selling, General, & Admin. Expense(SGA) was $1,302 Mil.
Total Current Liabilities was $1,120 Mil.
Long-Term Debt & Capital Lease Obligation was $2,481 Mil.
Net Income was -1068.1 + 557.6 + 889 + 467.6 = $846 Mil.
Non Operating Income was -2032 + -49.2 + 78.2 + -6.7 = $-2,010 Mil.
Cash Flow from Operations was 790 + 549.6 + 517.1 + 599.5 = $2,456 Mil.
Accounts Receivable was $1,124 Mil.
Revenue was 1203.3 + 1140.4 + 1128.8 + 1026.5 = $4,499 Mil.
Gross Profit was 1104.1 + 1054.6 + 1032 + 935.9 = $4,127 Mil.
Total Current Assets was $4,169 Mil.
Total Assets was $14,568 Mil.
Property, Plant and Equipment(Net PPE) was $1,333 Mil.
(DDA) was $397 Mil.
Selling, General, & Admin. Expense(SGA) was $1,158 Mil.
Total Current Liabilities was $1,032 Mil.
Long-Term Debt & Capital Lease Obligation was $2,604 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Accounts Receivable in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1372.2 / 5536.8) / (1123.6 / 4499)
=0.24783268 / 0.24974439
=0.9923

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4126.6 / 4499) / (5070.7 / 5536.8)
=0.91722605 / 0.9158178
=1.0015

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5367.9 + 1406.3) / 16703.2) / (1 - (4168.5 + 1333) / 14567.7)
=0.59443699 / 0.62234944
=0.9551

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5536.8 / 4499
=1.2307

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(397 / (397 + 1333)) / (362.2 / (362.2 + 1406.3))
=0.22947977 / 0.20480633
=1.1205

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1301.6 / 5536.8) / (1158.2 / 4499)
=0.23508164 / 0.25743499
=0.9132

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2481 + 1120.1) / 16703.2) / ((2603.8 + 1031.5) / 14567.7)
=0.21559342 / 0.24954523
=0.8639

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(846.1 - -2009.7 - 2456.2) / 16703.2
=0.0239

An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.

Alexion Pharmaceuticals has a M-score of -2.11 signals that the company is likely to be a manipulator.


Alexion Pharmaceuticals Beneish M-Score Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)